T. Rowe Price Associates’s Legend Biotech LEGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.4M | Sell |
800,220
-5,929,559
| -88% | -$210M | ﹤0.01% | 881 |
|
|
2025
Q1 | $228M | Sell |
6,729,779
-78,302
| -1% | -$2.66M | 0.03% | 395 |
|
|
2024
Q4 | $222M | Sell |
6,808,081
-4,357,503
| -39% | -$142M | 0.03% | 405 |
|
|
2024
Q3 | $544M | Sell |
11,165,584
-323,691
| -3% | -$15.8M | 0.06% | 265 |
|
|
2024
Q2 | $509M | Buy |
11,489,275
+540,155
| +5% | +$23.9M | 0.06% | 260 |
|
|
2024
Q1 | $614M | Buy |
10,949,120
+140,904
| +1% | +$7.9M | 0.08% | 242 |
|
|
2023
Q4 | $650M | Buy |
10,808,216
+1,114,848
| +12% | +$67.1M | 0.09% | 215 |
|
|
2023
Q3 | $651M | Buy |
9,693,368
+662,044
| +7% | +$44.5M | 0.1% | 208 |
|
|
2023
Q2 | $623M | Buy |
9,031,324
+7,939,175
| +727% | +$548M | 0.09% | 220 |
|
|
2023
Q1 | $52.7M | Buy |
1,092,149
+437,630
| +67% | +$21.1M | 0.01% | 674 |
|
|
2022
Q4 | $32.7M | Sell |
654,519
-1,279
| -0.2% | -$63.8K | 0.01% | 776 |
|
|
2022
Q3 | $26.8M | Buy |
655,798
+88,643
| +16% | +$3.62M | ﹤0.01% | 824 |
|
|
2022
Q2 | $31.2M | Buy |
+567,155
| New | +$31.2M | ﹤0.01% | 1035 |
|
|
2021
Q2 | – | Sell |
-124,229
| Closed | -$3.61M | – | 2934 |
|
|
2021
Q1 | $3.61M | Sell |
124,229
-455,548
| -79% | -$13.2M | ﹤0.01% | 1544 |
|
|
2020
Q4 | $16.3M | Sell |
579,777
-5,731
| -1% | -$161K | ﹤0.01% | 1266 |
|
|
2020
Q3 | $18.1M | Sell |
585,508
-263,509
| -31% | -$8.13M | ﹤0.01% | 1177 |
|
|
2020
Q2 | $36.1M | Buy |
+849,017
| New | +$36.1M | ﹤0.01% | 962 |
|